Ask Warren

Aptabio Therapeutics

293780 · KOSDAQ · ₩293780 · 압타바이오

₩5,090▼ ₩220 (4.14%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

20252024202320222021
Revenue₩3.7B₩3.4B₩324M₩48M₩224M
Cost of sales₩2.4B₩3.1B₩245M——
Gross profit₩1.3B₩287M₩78M——
Operating income−₩16B−₩19B−₩16B−₩9.5B−₩11B
Net income−₩16B−₩29B−₩12B−₩11B−₩11B
Net income to shareholders−₩16B−₩29B−₩12B−₩11B−₩11B

Balance sheet

20252024202320222021
Total assets₩60B₩77B₩93B₩56B₩65B
Current assets₩25B₩35B₩57B₩20B₩24B
Cash and equivalents₩16B₩26B₩25B₩2B₩6.6B
Total liabilities₩13B₩23B₩31B₩3.7B₩3.2B
Current liabilities₩9.7B₩20B₩818M₩1B₩788M
Borrowings₩7.2B₩16B₩39B——
Total equity₩47B₩54B₩61B₩52B₩62B
Shareholders' equity₩47B₩54B₩61B₩52B₩62B

Cash flow

20252024202320222021
Cash from operations−₩15B−₩12B−₩14B−₩6.8B−₩8.9B
Free cash flow−₩15B−₩12B−₩14B−₩6.8B−₩8.9B

Consolidated where available. Amounts in won.

Also known as: Aptabio Therapeutics / 압타바이오 / 293780 / KRX:293780

Source: KRX statistical information